AUKELSO 120 mg/1.7mL
Denosumab-kyqq · INJECTION · Biocon Biologics Inc.
No Recall History
Plain English
AUKELSO is a injection containing denosumab-kyqq at 120 mg/1.7mL, taken subcutaneous. Manufactured by Biocon Biologics Inc..
Key Facts
- Brand Name
- AUKELSO
- Generic Name
- Denosumab-kyqq
- NDC Code (Product)
83257-030- Manufacturer
- Biocon Biologics Inc.
- Strength
- 120 mg/1.7mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761436
- Drug Class
- RANK Ligand Inhibitor [EPC]
- Marketing Start
- 01/05/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is AUKELSO used for?
AUKELSO contains Denosumab-kyqq. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is AUKELSO a controlled substance?
AUKELSO is not classified as a controlled substance by the DEA.
What is the generic name for AUKELSO?
The generic name for AUKELSO is Denosumab-kyqq. There are 1 other brand versions of Denosumab-kyqq.
What is the NDC code for AUKELSO 120 mg/1.7mL?
The NDC (National Drug Code) for AUKELSO 120 mg/1.7mL is 83257-030, listed by Biocon Biologics Inc..